Ositab is one of the recommended brands in the oncology division that manage the EGFR mutated NSCLC (Non-small cell lung cancer) in patients who have already progressed on or after taking EGFR TKI therapy. It comes in two dose forms and is prescribed accordingly based on the clinical condition of the patient. Click on the appropriate link below to view more details like uses, composition, and description of the products.
Clexza is a BCL-2 inhibitor for the treatment of adult patients with Chronic Lymphocytic Leukemia or Smal Lymphocytic Leukemia Clexza is also used in combination with Azacitadine or Decitabine for newly diagnosed AML in adults who are 75 years or older or who have comorbidities that preclude use of intensive induction chemotherapy
To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.
Plot Nos. M-22 & M-25; Motanga Industrial Park, S/Jongkhar, Bhutan
Plot Nos. M-22 & M-25; Motanga Industrial Park, S/Jongkhar, Bhutan
